Abstract
The COVID-19 pandemic has afflicted most countries on the planet. As a result, immunity against SARS-CoV-2, induced via natural infections or imminent vaccinations, is expected to develop in a large fraction of the global population. Here, we propose to exploit SARS-CoV-2-specific CD8 + T cells for cancer immunotherapy strategies.
Keywords: CD8+ T cell epitopes; SARS-CoV-2; antigen spreading; antiviral immunity; cancer immunotherapy.
All Keywords
【저자키워드】 SARS-CoV-2, antiviral immunity, CD8+ T cell epitopes, antigen spreading, cancer immunotherapy., 【초록키워드】 Cancer immunotherapy, Immunity, Antiviral, COVID-19 pandemic, CD8, Antigen, T cell, natural infection, Vaccinations, fraction, CD8+, country, develop, expected, 【제목키워드】 COVID-19, Immunity, Cancer, repurposing, CD8, T cell, positive,
【저자키워드】 SARS-CoV-2, antiviral immunity, CD8+ T cell epitopes, antigen spreading, cancer immunotherapy., 【초록키워드】 Cancer immunotherapy, Immunity, Antiviral, COVID-19 pandemic, CD8, Antigen, T cell, natural infection, Vaccinations, fraction, CD8+, country, develop, expected, 【제목키워드】 COVID-19, Immunity, Cancer, repurposing, CD8, T cell, positive,
{{{ 추상적인 }}}
COVID-19 전염병은 지구상의 대부분의 국가에 영향을 미쳤습니다. 그 결과, 자연 감염 또는 임박한 백신 접종을 통해 유도된 SARS-CoV-2에 대한 면역이 세계 인구의 많은 부분에서 발달할 것으로 예상됩니다. 여기에서 우리는 암 면역 요법 전략을 위해 SARS-CoV-2 특이적 CD8 + T 세포를 활용하는 것을 제안합니다.
{{ 키워드: }} CD8+ T 세포 에피토프; 사스 코로나바이러스 2; 항원 확산; 항바이러스 면역; 암 면역 요법.